Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Deciding between broad market and sector funds depends on diversification needs and risk tolerance. This guide compares outcomes and helps you decide.
28,547 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Just getting started with crypto? Knowing the right starting stake matters. This guide breaks down the average invest...
As June 2026 begins, investors weigh which bitcoin, xrp, ethereum, or Solana will bounce back first amid macro shifts...
U.S. equities extended gains as investors digested a leadership shift at the Federal Reserve and a cautious path for ...
U.S. savers are seeing a wave of HYSA promotions with big headline yields that may fade after a short window. This pi...
Stellar leads in on-chain real-world asset tokenization, but XRP still dominates in price. The divergence spotlights ...
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Marvell Technology has bold dreams about joining the trillion-dollar club. This article lays out a practical timeline...
As issuance climbs in 2026, the market sees the biggest borrowers riding the strongest credits while risk signals rem...
Bitcoin investment products suffer $1.44 billion in net outflows, marking the heaviest weekly drain in 2026 and signa...
SanDisk’s flash-storage division posted stronger-than-expected results as data-center demand and AI workloads surge. ...
Investors often wonder if Nvidia stock should be bought before major AI events. This article breaks down historical p...